MAR 09, 2015 4:19 PM PDT

Magnetic Material Attracts Attention for Cancer Therapy

WRITTEN BY: Ilene Schneider
An extraordinary self-regulating heating effect that can be achieved in a particular type of magnetic material may open the doors to a new strategy for hyperthermia cancer treatment.

Temperatures that can be tolerated by healthy body cells have long been known to destroy cancerous cells. An approach that uses magnetic particles that are introduced into tissue and heated remotely has found some success in treating cancer, but the technique is still some way from becoming a standard procedure.



One of the problems hindering progress is the insufficient heating capacity of magnetic particles. However, researchers led by Professor Kiyonori Suzuki at Monash University have found a material that not only heats rapidly: it also stops quickly and cannot go on getting hotter.

What is more, the temperature it reaches is high enough to destroy tumour tissue, but too low to affect normal healthy tissue.

"This strong, self-regulated heating effect is unmatched by other materials," Professor Suzuki said. "It opens a novel design strategy for realising in vivo hyperthermia therapy."

The team, which includes other researchers from Monash as well as Professor Karl G Sandeman of CUNY-Brooklyn College and Imperial College London, is investigating well-known magnetocaloric materials known as first-order magnetic materials, which so far have attracted research interest chiefly for magnetic refrigeration.

The exciting qualities of these materials are tied to their Curie temperature - the point (which varies for different materials) at which magnetic properties undergo change.

"We chose these materials for our study because the Curie point resides in the ideal temperature range for hyperthermia treatment of cancer cells," Professor Suzuki said.

A critical factor in the extraordinarily large heating power is the first order Curie transition. This is unlike the conventional Curie transition in that two magnetic states coexist. For complex reasons tied to this coexistence, the conversion of external magnetic fields to heat is maximized near the Curie temperature - and then above this temperature, the conversion effect abruptly stops.

The researchers are hoping that their proof-of-concept study, which was published in Applied Physics Letters, could pave the way for enhanced cancer therapies.

Source: Monash University
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 20, 2019
Immunology
NOV 20, 2019
Harnessing the Power of Natural Killer Cells to Fight Cancer
Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results invest...
DEC 02, 2019
Cancer
DEC 02, 2019
What patients don't know: the side effects of cancer treatment
If anyone you know has ever had to go through treatment for cancer, or if you yourself have had to, you know that fighting the cancer is only part of the b...
JAN 14, 2020
Cancer
JAN 14, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
JAN 22, 2020
Cancer
JAN 22, 2020
How the VISTA molecule affects immune responses
A new study describes how a molecule named VISTA has been impeding immune responses in cancer therapies. By turning this molecule “off,” resear...
JAN 23, 2020
Cancer
JAN 23, 2020
The role of circular RNA in melanoma
New research published in the journal Cancer Cell investigates the role of circular RNAs in the spread of melanoma. Melanoma is a particularly aggressive c...
JAN 20, 2020
Technology
JAN 20, 2020
Open-Source Software Judges The Accuracy of Cancer Predicting Computer Programs
Cancers are generally composed of diverse cells that vary in genetics—these variations often make a particular cancer more susceptible or resistant t...
Loading Comments...